MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
2026: OPMED 2026_Operational Medicine (OpMed) SYMPOSIUM & TECHNOLOGY SHOWCASE March 17-18 2026, San Antonio, Texas
Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. (HJF)
Organization & Developments: HJF (Henry M. Jackson Foundation)
HJF: Locations
Japan
Industry: Japan
Shin Nippon Biomedical Laboratories (SNBL)
Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA)
Organization & Developments: Satsuma Pharmaceuticals
Parents
Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA)
Children
2020: Phase III migraine flop sends a small-cap biotech player into a deadly tailspin
2021: Satsuma Pharmaceuticals: Sizing Up This One Trick Pony
2021: Satsuma: Launch Of 2nd Pivotal Trial For Migraine Med Ought To Cheer Share Price
Clinical-stage biopharmaceutical company focused on developing STS101 (dihydroergotamine mesylate (DHE) nasal powder) as an important and differentiated therapeutic option for the acute treatment of migraine.
Jumps
*Key People: Satsuma Pharmaceuticals
Finance & Acquisitions: Satsuma Pharmaceuticals